A proposed methodology to select radioisotopes for use in radionuclide therapy

American Journal of Neuroradiology

Volumn 30, Issue 10, 2009, Pages 1824-1829

  Cuaron, J J ^a   Hirsch, J A ^b   Medich, D C ^c   Rosenstein, B S ^d,e   Martel, C B ^f   Hirsch, Ariel E ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; BISMUTH 212; BONE CEMENT; CESIUM 137; FLUORINE 18; HOLMIUM; HOLMIUM 166; IODINE 125; IRIDIUM 192; MICROSPHERE; PALLADIUM 103; PHOSPHORUS 32; POLY(METHYL METHACRYLATE); RADIOISOTOPE; RADIUM 224; TECHNETIUM 99M; UNCLASSIFIED DRUG; YTTERBIUM; YTTERBIUM 90;

CANCER RADIOTHERAPY; COMPRESSION FRACTURE; DOSIMETRY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; HALF LIFE TIME; HUMAN; INTERVENTIONAL RADIOLOGY; METHODOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS VERTEBROPLASTY; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SPINE CANCER; SPINE FRACTURE; SPINE METASTASIS; STAFF TRAINING; TREATMENT PLANNING; VERTEBRA FRACTURE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; NUCLEAR MEDICINE; PRACTICE GUIDELINES AS TOPIC; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY;

EID: 71449083064     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1773     Document Type: Review

References (34)

1. Jensen ME, Evans AJ, Mathis JM, et al. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol 1997;18:1897-1904
2. Jensen ME, McGraw JK, Cardella JF, et al. Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, and American Society of Spine Radiology. AJNR Am J Neuroradiol 2007;28:1439-1443 (Pubitemid 47462923)
3. Hirsch AE, Medich DC, Rosenstein BS, et al. Radioisotopes and vertebral augmentation: dosimetric analysis of a novel approach for the treatment of malignant compression fractures. Radiother Oncol 2008;87:119-126 Epub 2008 Feb 7
4. Larson SM, Krenning EP. A pragmatic perspective on molecular targeted radionuclide therapy. J Nucl Med 2005;46(suppl 1):1S-3S
5. Delclos L. Are interstitial radium applications passé? Front Radiat Ther Oncol 1978;12:42-56
6. Schaeflein JW, Schlesinger T, Stephens SO, et al. Some observations on iridium 192. Front Radiat Ther Oncol 1978;12:13-20
7. Allen BJ, Raja C, Rizvi S, et al. Targeted alpha therapy for cancer. Phys Med Biol 2004;49:3703-3712
8. Allen BJ. Clinical trials of targeted alpha therapy for cancer. Rev Recent Clin Trials 2008;3:185-191
9. Rosenkranz AA, Vaidyanathan G, Pozzi OR, et al. Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At. Int J Radiat Oncol Biol Phys 2008;72:193-200
10. Song H, Shahverdi K, Huso DL, et al. 213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model. Cancer Res 2008;68:3873-3880
11. Serafini AN, Houston SJ, Resche I, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 1998;16:1574-1581 (Pubitemid 28175783)
12. American National Standards Institute, Inc. ANSI/HPS N43.6-2007. Sealed Radioactive Sources-Classification. Health Physics Society, 2007. Available at: http://www.hps.org/hpssc/documents/standards-Order-Form1.pdf. Accessed October 24, 2008
13. Fischer H, Aiginger H, Havlik E, et al. Radionuclidic purity aspects of 153Sm for radionuclide therapy. Presented at: International Congress of the International Radiation Protection Agency, Madrid, Spain, May 23-28, 2004
14. Uusijärvi H, Bernhardt P, Ericsson T, et al. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution. Med Phys 2006;33:3260-3269 (Pubitemid 44327428)
15. Hall E, Giaccia AJ. Radiobiology for the Radiologist. 6th ed. Philadelphia: Lippincott Wilkins & Williams; 2006
16. Setlow P. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 2006;101:514-25, 2006
17. Atcher RW, Friedman AM, Hines JJ. An improved generator for the production of 212Pb and 212Bi from 224Ra. Int J Rad Appl Instrum A 1988;39:283-286
18. Larsen RH, Wieland BW, Zalutsky MR. Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (alpha,2n)211 at reaction. Appl Radiat Isot 1996;47:135-143
19. Tolmachev V, Carlsson J, Lundqvist H. A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy: availability of suitable radionuclides. Acta Oncol 2004;43:264-275 (Pubitemid 38757048)
20. Lindegren S, Bäck T, Jensen HJ. Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields. Appl Radiat Isot 2001;55:157-160 (Pubitemid 32241030)
21. Minar E, Pokrajac B, Ahmadi R, et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 1998;208:173-179 (Pubitemid 28323327)
22. Ricke J, Wust P, Wieners G, et al. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest 2006;127:2237-2242 (Pubitemid 46260119)
23. Zhang FJ, Wu PH, Zhao M, et al. CT guided radioactive seed 125I implantation in treatment of pancreatic cancer [in Chinese]. Zhonghua Yi Xue Za Zhi 2006;86:223-227 (Pubitemid 43210477)
24. Zhang FJ, Li CX, Wu PH, et al. Radioactive seed 125I implantation in treating recurrence and metastasis after liver transplantation in hepatoma [in Chinese]. Zhonghua Yi Xue Za Zhi 2007;87:956-959
25. Zhang FJ, Li CX, Wu PH, et al. CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma [in Chinese]. Zhonghua Yi Xue Za Zhi 2007;87:3272-3275
26. Jiang Y, Huang ZL, Wu PH, et al. Short-term efficacy of CT-guided radioactive seed 125I implantation on residual or relapsing metastatic lymph nodes in advanced tumor patients after multi-modality treatment [in Chinese]. Ai Zheng 2008;27:1082-1087
27. Zhang L, Fan WJ, Huang JH, et al. CT guided 125I seeds implantation in treatment of local recurrent rectal cancer after surgery resection: analysis of 21 cases [in Chinese]. Zhonghua Yi Xue Za Zhi 2008;88:1335-1338
28. Zhang JQ, Huang XQ, Zhang J, et al. CT guided radioactive seed (125)I implantation in treating multiple bone metastasis [in Chinese]. Zhonghua Yi Xue Za Zhi 2008;88:2739-2742
29. Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994;35:1637-1644
30. Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum 1979;22:371-375 (Pubitemid 10211459)
31. Ariel IM, Pack GT. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer 1967;20:793-804
32. Mantravadi RV, Spigos DG, Tan WS, et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982;142:783-786
33. Feinendegen LE. Microdosimetric considerations of hepatic radioembolization. J Nucl Med 1994;35:1644-1646
34. Ibrahim SM, Lewandowski RJ, Sato KT, et al. Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol 2008;14:1664-1669